Supplementary Figure 6 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes

Raffaele De Palma,Ilaria Marigo,Francesco Del Galdo,Carmela De Santo,Paolo Serafini,Sara Cingarlini,Thomas Tüting,Julia Lenz,Giuseppe Basso,Gabriella Milan,Paola Zanovello,Vincenzo Bronte

crossref（2023）

Cited 0|Views11

No score

Abstract

Supplementary Figure 6 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8⁺ T Lymphocytes

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined

Supplementary Figure 6 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8&lt;sup&gt;+&lt;/sup&gt; T Lymphocytes

Supplementary Figure 6 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes